nir

/nir

About nir

This author has not yet filled in any details.
So far nir has created 203 blog entries.

Oramed Granted Japanese Patent for GLP-1 Analog Capsule

NEW YORK, July 24, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent [...]

2018-07-24T08:26:00+00:00 Categories: Press Releases|Tags: |

Oramed Announces Closing of $18.1 Million Registered Direct Offering

NEW YORK, July 6, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the closing of its previously-announced registered direct offering with several healthcare-focused institutional investors. Oramed has sold $18.1 [...]

2018-07-06T17:00:00+00:00 Categories: Press Releases|Tags: |

Oramed Announces $18.1 Million Registered Direct Offering

NEW YORK, July 3, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has entered into definitive agreements with several healthcare-focused institutional investors for the purchase in [...]

2018-07-03T01:49:00+00:00 Categories: Press Releases|Tags: |

Oramed to be Added to Russell Microcap® Index

NEW YORK, June 19, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc.(NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be added to the FTSE Russell Microcap® Index effective at the open of market [...]

2018-06-19T08:25:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Conferences in May

NEW YORK, May 7, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will present at three conferences over the next two weeks. DG Disruptive Growth [...]

2018-05-07T08:25:45+00:00 Categories: Press Releases|Tags: |